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(e emerging concern about the increase of antibiotic resistance and associated bioﬁlm has encouraged scientists to look for
alternative antibiotics such as antimicrobial peptides (AMPs). (is study evaluated the ability of melittin to act as an antibacterial
bioﬁlm inhibitor and bioﬁlm remover considering isolates from dairy industry. Minimum inhibitory concentrations (MICs),
minimum bactericidal concentrations (MBCs), minimum bioﬁlm inhibitory concentrations (MBICs), and bioﬁlm removal activities
were studied in polymicrobial bioﬁlms produced from isolates. MIC and MBC were set at 1–3 µg/mL and 25–50 µg/mL for Gram-
positive and Gram-negative bacteria, respectively. Results demonstrated a good MBIC reaching 85% inhibition ability and a good
activity and better penetration in deeper layers against the mixed preformed bioﬁlm, thereby increasing its activity against all isolates
also at the lowest tested concentrations. Melittin showed interesting characteristics suggesting its potential to act as an antimicrobial
agent for polymicrobial bioﬁlm from dairy industry even in environmental isolates.
1. Introduction
(ere is a pressing need to develop new antimicrobial agents
active against bacteria and able to avoid drug resistance in
order to face the huge public health problem correlated to
the increasing emergence of multidrug-resistant bacteria
[1, 2].
Antimicrobial peptides (AMPs) are an attractive solution
as therapeutic agents, for their capability to kill a broad range
of bacteria (including multidrug-resistant strains), fungi,
and viruses and reducing the development of drug resistance
[3–6]. Natural antimicrobial peptides (i.e., >750 com-
pounds) are considered alternative agents with new active
mechanisms of action and a wide diversity of active prin-
ciples [7]. Bee venom (BV) is a complex mixture of peptides,
enzymes, and biogenic amines possessing several pharma-
ceutical properties, whose main peptidic components are
melittin and apamin. Melittin is a water-soluble toxic 26
amino acid peptide. It constitutes about 40–50% of the dry
weight of BV being the most active toxin. It has antibacterial,
antiviral, anti-inﬂammatory, and antiﬁbrotic properties
[8–11], developing a rapid cytolytic action and destabilizing
membranes of diﬀerent cell types [12–15]. Melittin presents
a strong binding aﬃnity with membranes due to its
amphiphilicity, which is correlated to the asymmetric dis-
tribution of polar and nonpolar side chains. (is ability
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provides its therapeutic potential for various bacterial and
viral diseases, as well as inﬂammatory events and cancers.
An important public health concern is represented by
antimicrobial resistance in bacteria potentially transmitted
by foods, and studies have been recently devoted to
unravelling possible factors inﬂuencing the emergence of
antimicrobial-resistant bacteria in the food chain. Globally,
foodborne diseases are now among the most widespread
public health problems due to contamination during pro-
duction, collection, transportation, processing, and storage
[16–18].
(e ability of microorganisms to resist to adverse factors
and colonize the environment is further enhanced by bioﬁlm
production. Bioﬁlms are sessile bacterial communities at-
tached to a substrate and embedded in a self-produced
extracellular polymeric matrix. In this polymeric matrix,
cells exhibit a distinct phenotype, metabolism, physiology,
and gene expression compared to the planktonic ones [19].
Bacterial bioﬁlms are a source of constant contamination
of the product and thus represent a risk in the food industry.
In particular, all places where food comes in contact with
food are subject to this problem, such as stainless steel pipes,
utensils, tables [20–22]. Furthermore, in the food industry,
the common disinfecting agents used for food facilities could
have negative eﬀects, such as the toxicity of residues, the
promotion of microorganisms resistance [23], and a de-
creasing susceptibility of bioﬁlms to them.
In recent years, lot of eﬀorts has been made to ﬁnd new
antibiotics to which bacteria forming bioﬁlm cannot develop
resistance. Antimicrobial peptides, isolated from natural
sources, including mammals, insects, and plants, have
emerged as good candidates [24]. Especially, some venoms
were reported to have antibioﬁlm activity [25].
To guarantee the optimal level of equipment hygiene in
the dairy industry, it is necessary not only to kill bacteria and
to inhibit their capacity to form bioﬁlms but also to remove
eﬀectively from surface-attached bacteria.
(is study aimed at investigating new antimicrobial
molecules from natural compounds having eﬀective struc-
tures such as melittin. (is study was carried out to (i)
evaluate the ability of strains isolated from dairy industry to
form bioﬁlms on hydrophobic surfaces at 37°C; (ii) de-
termine the minimum inhibitory concentrations (MICs),
minimum bactericidal concentrations (MBCs), and mini-
mum bioﬁlm inhibitory concentrations (MBICs) of melittin
on dairy industry isolates; and (iii) test the ability of melittin
to inhibit and to eradicate their bioﬁlms formation.
2. Materials and Methods
2.1. Melittin Production. Melittin was obtained using
standard solid-phase-9-ﬂuorenylmethoxycarbonyl (Fmoc)
method a on a Rink amide MBHA resin (scale of 50mmol)
as previously reported [26].
2.2. Collection of Samples. Samples were collected in a dairy
plant tank used for mozzarella cheese production located in
Campania region (Italy) after cleaning procedures. For
surface samples from post-disinfection tub, sterile swabs
moistened in saline (0.85%) with peptone (0.1%) and sodium
thiosulfate (0.01%) were used in the deﬁned area of 100 cm2
following the ISO 18593 : 2004 [27]. From collected samples,
isolation of typical colonies was performed according to ISO
4833-1 : 2013, ISO/TS 11059 : 2009, ISO 6888–1 : 2004, ISO
4832 : 2006, and ISO 16649–2 : 2001 [27–31]. Isolates were
maintained at −18°C until DNA extraction. Samples selec-
tion of the strains to be used in the experiments was per-
formed after bioﬁlm production assay. From the total of
isolates, four were selected as bioﬁlm producers. (e capital
letters before strains indicated the isolation origins, so R1-R2
mildly forming bioﬁlm, R3 strongly forming bioﬁlm, and R4
weakly forming bioﬁlm strains were selected for our study
and molecularly identiﬁed.
2.3. Molecular Characterization. One colony from the se-
lective medium containing our isolates was reconstituted with
50 μL Milli-Q Type 1 Ultrapure Water and DNA extracted
through denaturation at 96°C for 10minutes and then
centrifuged at 10,000 rpm for 10min at 4°C [32]. (e su-
pernatant was recovered and used for polymerase chain re-
action. PCRs were carried out in a Techne Prime (ermal
Cycler.(e bacterial DNAwas ampliﬁed using universal PCR
primers, complementary to V3 and V6 regions (16S rDNA)
[33]. (e selected oligos were V3_F (5’CCAGACTCCT
ACGGGAGGCAG-3’) and V6_R (5’-TCGATGCAACGC-
GAAGAA-3’). A typical 25 μl PCR reaction contained 50 μM
of each invA primer, 0.2 μMof each dNTP (VWRChemicals),
PCR Key Buﬀer Triton Free (Tris-HCl, pH 8.5, KCl, 15mM
MgCl2 (VWR Chemicals)), 1 μ VWR Taq DNA polymerase
(VWR Chemicals), and 0.5μL sample DNA. (e incubation
conditions were 95°C for 2min (initial denaturation), fol-
lowed by 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for
45 s. A ﬁnal extension of 72°C for 5minutes was employed.
(e ampliﬁed products were visualized and analyzed for size
on agarose gel (1.5%), stained with GelRed (nucleic acid gel
stain-BIOTIUM) using DNA 100 bp ladder as a reference.
DNA sequencing was performed by Bio-Fab research s.r.l.
(Italy). Sequences obtained were compared and aligned to
those available in the NCBI sequence database.
2.4. Bioﬁlm Production. Strains were cultured in 5mL
tryptone soya broth (TSB) medium (Difco) for 24 h at 37°C
and were suspended at 107 cells/mL in fresh TSB. (en,
100 µl of the suspension was added into individual wells of
polystyrene 96-well plates and incubated at 37°C for 24 h to
allow the develop of the bioﬁlm. (e total biomass of the
bioﬁlm was analyzed using the Crystal violet (CV) staining
method [34], as described elsewhere [3, 35]. Brieﬂy, after the
incubation, wells were washed with 300 µL of PBS to remove
unattached bacteria and air-dried at 60°C for 60min. (en,
150 µL of CV (0.2% p/v) was added to each well and in-
cubated for 15min. After washing the wells with deionized
water, excess stain was gently rinsed oﬀ with tap water. CV
bound to the bioﬁlm was detached using 150 µL of 30% v/v
acetic acid for 30min at room temperature, and the
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absorbance at 570 nm was detected with a spectropho-
tometer (DR5000, HACH).
2.5.MIC andMBCDetermination. MICs of melittin, on our
isolates, were determined with a microbroth dilution
technique as described by the Clinical and Laboratory
Standards Institute [36] (CLSI, 2006 M7-A6) using TSB.
Melittin was tested at concentrations ranged from 5 to
100 µg/ml. Plates were incubated at 37°C for 24 h and ex-
amined. Wells without the test molecule served as control.
(e MIC was deﬁned as the lowest concentration of peptide
that completely inhibited visible growth analyzed at 590 nm
using a microplate reader (Synergy H4 BioTek). MBCs were
determined at the end of the incubation period by sub-
culturing 10 µl samples from each well, demonstrating no
visible growth and plated onto tryptic soy agar (TSA, Difco
Laboratories) medium plates. Resultant colonies were
counted after an overnight incubation at 37°C.(eMBCwas
deﬁned as the lowest concentration of antimicrobials that
killed at least 99.9% of the initial inoculums [37]. All tests
were performed in triplicate. (e MBC/MIC ratio was
calculated to determine whether the substance had a bac-
teriostatic (MBC/MIC≥ 4) or bactericidal (MBC/MIC< 4)
activity [38].
2.6. Inhibition and Eradication of Bioﬁlm Formation Test.
Pseudomonas aeruginosa strain RMR101 (R1), Staphylo-
coccus haemolyticus strain M2 (R2), Klebsiella pneumoniae
strain 459 (R3), and Aeromonas caviae strain 8LM (R4) were
grown overnight at 37°C in TBS, washed twice in PBS, and
resuspended to obtain a suspension equivalent to
1× 105 cells/ml (OD600) when we tested each one bioﬁlms
and 2,5×104 cells/ml each when we tested all four bioﬁlms
together. 100 μl of each inoculum was dispensed into wells of
96-well microtiter plates.
To prevent cells adherence and to value the capacity to
form bioﬁlms at the intermediate stage (24 h bioﬁlms), the
plates were incubated at 37°C for 24 h with melittin at
concentration of 5–100 µg/ml, while to eradicate preformed
bioﬁlm at the maturation stage (48 h bioﬁlms), the plates
were incubated for 48 h, the medium was renewed after 24 h,
and melittin at the same concentrations was added at the last
24 h.
Bioﬁlms formed by bacteria that did not undergo any
treatment with melittin were used as controls for compar-
ison with the means of the treatments.
(e eﬀect of melittin on bioﬁlm inhibition and eradication
was quantiﬁed by using the XTT assay that analyzed the
density of the adhered cells, measuring the relative metabolic
activity using the XTT (2,3-bis (2-methoxy-4-nitro-5-sulfo
phenyl)-5-(phenylamino) carbonyl)-2H-tetrazolium hydrox-
ide) colorimetric assay kit (Sigma) following manufacturer’s
instructions as descripted elsewhere [39].
Scanning electron microscopy (SEM) was used to vi-
sualize the eﬀect of melittin on the bioﬁlm eradication.
Preparation of samples for SEMwas performed as previously
described [40].
Data were assessed considering the analysis of variance
(ANOVA) and Tukey’s test to check any diﬀerence among
the groups after lognormal transformation of concentration
data using Microsoft® Excel 2013/XLSTAT©-Pro (version7.2, Addinsoft, Inc., Brooklyn, NY, USA). When ANOVA
revealed signiﬁcant diﬀerences among treatments, post hoc
tests were carried on with Dunnett’s method testing the
pairwise diﬀerence between each treatment and the control.
Parametric methods were considered for points’ estimation.
Pearson correlation analysis was used to compare the in-
hibition and eradication of single as well as polymicrobial
bioﬁlms (PMBs) (p< 0.05).
3. Results and Discussion
Isolates from dairy industry products that showed bioﬁlm
formation activity were selected to determine the nucleotide
sequence of nearly the entire length of the 16S rRNA gene,
and results are reported in Table 1. R1 was Klebsiella
pneumoniae 459, R2 was Staphylococcus haemolyticus M2,
R3 was Pseudomonas aeruginosa RMR101, and R4 was
Aeromonas caviae 8LM. (e assessment of bioﬁlm biomass
production permitted to classify one as strong bioﬁlm
producer (R3), two as moderate bioﬁlm producers (R1-R2),
and one as weak producer (R4) (Figure 1). Because all four
strains came from the same area after common disinfection
procedures, we tested the ability to form bioﬁlm together
and we found that they were strongly bioﬁlm producers as
shown in Figure 1.
Determination of MIC and MBC values of melittin
against Gram-positive and Gram-negative environmental
isolates (R1–R4) are summarized in Table 2. Melittin
exhibited a broad spectrum of antibacterial activity against
both Gram-positive (MIC values 1–5 µg/mL) and Gram-
negative bacteria (MIC values between 50 and 100 µg/mL).
In the case of P. aeruginosa, melittin showed only bacterio-
static activity at considered concentrations (up to 100 µg/mL).
Bacteria forming bioﬁlms may be up to 1000 times more
resistant to antimicrobial agents than those in a planktonic
state. To evaluate the eﬃcacy of melittin on the bioﬁlm
formation, either MIC or sub-MIC concentrations were
used. Signiﬁcant to moderate bioﬁlm, reducing activity was
observed for concentrations lower than these found forMIC.
Melittin showed a dose-dependent inhibition of bioﬁlm
development according to the following equation:
Y�−10 + 42 logX (X� inhibition concentration; Y�% in-
hibition; R2 � 0.86; MSE� 142) (Figure 2). At the concen-
tration of 5 µg/ml, the inhibition reached 15%, while we have
a 50% inhibition of PMB at 50 µg/ml. In general, the in-
hibitory eﬀect of melittin increased with increasing con-
centrations and the eﬀect seemed to be dose-dependent.
To corroborate the antibioﬁlm data, a colorimetric assay
was performed to quantify bioﬁlms remaining on surfaces
after treatment. Results normalized to untreated controls
(Figure 3) evidenced a dose-dependent percentage of eradi-
cation according to the following equation: Y� 9+ 19 logX
(X� inhibition concentration; Y�% inhibition; R2 � 0.89;
MSE� 21). When we used the same concentrations to de-
termine the ability of melittin to disperse mature bioﬁlms, a
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signiﬁcantly reduced bioﬁlm mass at sub-MIC and MIC
concentrations was noticed as shown in Figure 3. For ex-
ample, the concentrations at 10 and 25 µg/ml could disperse
the preformed bioﬁlms by 30% and 45%, respectively,
showing an interesting better work of melittin on preformed
bioﬁlm at concentrations lower than for inhibition.
In addition, Pearson correlation analysis revealed as
shown in Table 3 a positive and signiﬁcant correlation be-
tween inhibition and eradication of single andmixed bioﬁlms.
SEM images after 48 h showed that melittin exposure
had a great inﬂuence on the morphology and structure of
mixed bioﬁlms inﬂuencing both Gram-positive and Gram-
negative bacteria. Melittin showed a reduction in bioﬁlm
formation and a variability in the thickness, with scattered
damaged or dead cells, (Figure 4) conﬁrming the data ob-
tained by crystal violet and XTT assays.
(ree main ways can be used to control bioﬁlm for-
mation: reduction of the planktonic cells before bioﬁlm
formation, initial prevention of cell adhesion to surfaces, and
removal of mature bioﬁlms.
It has been demonstrated in a lot of studies that peptides
or antibiotics were able to inhibit the initial bioﬁlm at-
tachment (58–62%) at sub-MIC values. Probably, these
molecules interact with bacterial adhesins that mediates the
intercellular adhesion of bacteria to the surfaces [11].
Anyway, inhibition of bioﬁlm formation in early critical
stages is more applicable than inhibiting mature bioﬁlm.(e
antibioﬁlm activities of AMPs are not completely un-
derstood, and there are a small number of studies that have
Table 1: (e nucleotide sequences of the 16s rRna gene of the
isolates were compared with the known 16s rRna gene nucleotide
sequences available in the ddBJ/genbank/emBl databases using the
NCBI sequence database. Accession numbers for the available 16s
rrna gene sequences used are given in parentheses after the species
and strain names.
Sample Strains
R1 Klebsiella pneumoniae strain 459 chromosome,complete genome (KM609195.1 MF321768.1)
R2
Staphylococcus haemolyticus strain M2_0m_PrM_10
16S ribosomal RNA gene, partial sequence
(KY742479.1 KX946163.1)
R3
Pseudomonas aeruginosa strain RMR101 16S
ribosomal RNA gene, partial sequence (CP018306.1
MG396990.1)
R4 Aeromonas caviae strain 8LM chromosome, completegenome (CP024198.1 KX980472.1)
Mix R1+R2 +R3 +R4
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Figure 1: Total biomass ofmonomicrobial and polymicrobial bioﬁlms
of the diary isolates adhered on polystyrene. Negative (OD≤ODc),
weak (ODc≤OD≤ 2.ODc), moderate (2.ODc<OD≤ 4.ODc), and
strong bioﬁlm production (4.ODc<OD). Mix�R1+R2+R3+R4;
OD� optical density.
Table 2: Minimum inhibitory concentration (MIC) and minimum
bactericidal concentration (MBC) of melittin against environ-
mental isolates.
MIC
(µg/mL)
MBC
(µg/mL)
MIC/MBC
ratio
K. pneumoniae 50 100 2 Bactericide
S. haemoliticus 1 3 3 Bactericide
P. aeruginosa 100 >100 — Bacteriostatic
A. cavia 25 50 2 Bactericide
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Figure 2: Eﬀect of melittin on the inhibition of polymicrobial
bioﬁlm; data with diﬀerent letters (a–d) are signiﬁcantly diﬀerent
(Tukey’s, p< 0.05).
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Figure 3: Action of melittin on eradication of polymicrobial
bioﬁlm; data with diﬀerent letters (a–d) are signiﬁcantly diﬀerent
(Tukey’s, p< 0.05).
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marked possible explanations including matrix disruption,
binding of DNA, and altering the expression of bioﬁlm-
related genes, such as the production of pili, quorum sensing
systems, and ﬂagella assembly, and their dual capacity to act
on both the cytoplasmic membrane and intracellular targets
[13, 23]. Several investigations have demonstrated the an-
tibacterial activity of melittin [41]. Our results agree with
Picoli et al. [25], which determined a higher sensitivity of
Gram-positive microorganisms to melittin compared to the
Gram-negative ones mainly due to their structural diﬀer-
ences. Melittin can penetrate the peptidoglycan layer and
reach the Gram-positive cell membrane more easily than in
Gram-negative cells that have their membrane protected by
a layer of lipopolysaccharides.
(e industrial equipment used in cheese making and
processing is a source of contamination, and the ability of
microorganisms to adhere to the surfaces of them increases
their potential contamination.
Bioﬁlm formation is a process involving three stages: (i)
primary adhesion to surfaces; (ii) accumulation of multi-
layered cells; and (iii) detachment. Most infections are
caused by one single pathogen; however, polymicrobial
infections have attracted more attentions because PMBs are
the dominant form in nature. Synergistic, mutualistic, and
antagonistic interactions that occur between microorgan-
isms can collaborate to the growth of PMB communities,
resulting in a stronger bioﬁlm formation with increased
antimicrobial tolerance. In food industry, PMBs are an
important source of contamination for food and equipment,
and thus a major cause of foodborne disease outbreaks.
Results demonstrated that melittin not only can inhibit
early formation of PMBs in industrial equipment in a
concentration-dependent way but also could easily penetrate
the bioﬁlm matrix preformed and reduce cell populations at
sub-MIC concentrations.
Our data support the ﬁnding that melittin is more active
against Gram-positive than Gram-negative bacteria, and this
is due to the diﬀerent cell wall and membrane structure in
both types of bacteria so that melittin can penetrate the
peptidoglycan envelope and reach the cell membrane of
Gram-positive easier than for Gram-negative that are pro-
tected also by the lipopolysaccharide envelope [42].
(ese results suggest that melittin could be used in the
dairy food industry to control PMB formation, as an al-
ternative or in combination with conventional sanitizers.
4. Conclusions
Results suggested that PMBs inhibition and eradication from
diary isolates could be treated by melittin after usual
cleaning procedures to further remove any form of re-
sistance. Anyway, PMB cannot be always easily and eﬀec-
tively removed due to their great level of resistance and
diversity in the mix-of-species composition. Further studies
Table 3: Pearson’s correlation between species occurrence and contact time.
24 h 48 h K. pneumoniae S. haemoliticus P. aeruginosa A. cavia
24 h 20.995 0.925 0.593 0.974 0.907
48 h 20.995 20.951 −0.557 20.971 20.901
K. pneumoniae 0.925 20.951 0.535 0.896 0.804
S. haemoliticus 0.593 −0.557 0.535 0.560 0.682
P. aeruginosa 0.974 20.971 0.896 0.560 0.930
A. cavia 0.907 20.901 0.804 0.682 0.930
Values in bold are statistically signiﬁcant (p � 0.05).
Figure 4: Morphology of mixed bioﬁlm. (e morphology of bacteria in the mixed bioﬁlms visualized using the scanning electron mi-
croscope. Scale bar, 2 µm. Panel A corresponds to 48 h mixed bioﬁlms and panel B corresponds to treated 48 h mixed bioﬁlms. At least three
random ﬁelds were observed and analyzed, from three independent experiments.
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are required to understand themechanisms of action and the
better association between active antimicrobial molecules
and PMB mix-of-species.
Data Availability
(e data used to support the ﬁndings of this study are in-
cluded within the article.
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